Bioasis Technologies Balance Sheet - Annual (OTCMKTS:BIOAF)

Add to My Stocks
$0.32 $0.01 (3.23%) BIOAF stock closing price Sep 20, 2018 (Closing)

A thorough fundamental analysis involves using data from Bioasis Technologies balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Bioasis Technologies stock analysis. A company releases its balance sheet every year along with its annual results. Bioasis Technologies balance sheet indicates an asset turnover ratio of - and debt to equity ratio of -. Also check Bioasis Technologies revenue and Bioasis Technologies operating cash flow for the same period.

View latest 10 year balance sheet data to check Bioasis Technologies financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Mar - Feb201720162015201420132012
Cash--1.19M1.04M1.69M1.05M
Marketable Securities----1.5M-
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets------
Total Current Assets
-1.32M1.54M1.95M3.25M1.11M
Property Plant & Equipment------
Accumulated Depreciation------
Net Property Plant & Equipment
------
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles-----1.03M
Deposits & Other Assets------
Total Assets
-1.65M1.97M2.46M3.84M2.16M
Notes Payable------
Accounts Payable------
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities------
Total Current Liabilities
------
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
------
Minority Interest------
Preferred Stock------
Common Stock Net14.22M14.08M14.93M14.02M12.85M8.47M
Capital Surplus5.54M4.54M4.68M4.67M4.31M2.19M
Retained Earnings-19.48M-17.31M-17.82M-16.41M-13.56M-8.66M
Treasury Stock------
Other Liabilities------
Shareholders Equity-1.31M1.78M2.28M3.6M2M
Total Liabilities & Shareholders Equity-1.65M1.97M2.46M3.84M2.16M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Ascendis Pharma financial analysis

Looking at Bioasis Technologies historical stock prices and the current Bioasis Technologies stock price can tell you how the stock price has moved, whereas the Bioasis Technologies PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Bioasis Technologies owns and has monetary significance. BIOAF assets decreased from $1.65M in 2016 to $- in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. BIOAF stock had total liabilities of $- for the year 2017.

Bioasis Technologies Balance Sheet - Key Ratios

Current ratio
0
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0